Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/3115
Full metadata record
DC FieldValueLanguage
dc.contributor.author.Monahan, ShachamPatrick O-
dc.contributor.authorMichael Reece, Kurt Kroenke,-
dc.contributor.authorOng’or, Otieno OmolloWillis Owino-
dc.contributor.authorYebei, Claris OjwangViolet Naanyu-
dc.date.accessioned2020-07-27T08:35:47Z-
dc.date.available2020-07-27T08:35:47Z-
dc.date.issued2008-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/3115-
dc.description.abstractepression greatly burdens sub- Saharan Africa, especially populations living with HIV/ AIDS, for whom few validated depression scales exist. Patient Health Questionnaire-9 (PHQ-9), a brief dual- purpose instrument yielding DSM-IV diagnoses and severity, and PHQ-2, an ultra-brief screening tool, offer advantages in resource-constrained settings. and depression severity among adults living with HIV/AIDS in western Kenya. KEY WORDS: HIV/AIDS; Kenya; Africa; depression; PHQ-9. J Gen Intern Med 24(2):189–97 DOI: 10.1007/s11606-008-0846-z © Society of General Internal Medicine 2008 OBJECTIVE: To assess the validity/reliability of PHQ-9 and PHQ-2. DESIGN: Observational, two occasions 7 days apart. PARTICIPANTS: A total of 347 patients attending psychosocial support groups. MEASUREMENTS: Demographics, PHQ-9, PHQ-2, general health perception rating and CD4 count. RESULTS: Rates for PHQ-9 DSM-IV major depressive disorder (MDD), other depressive disorder (ODD) and any depressive disorder were 13%, 21% and 34%. Depression was associated with female gender, but not CD4. Con- struct validity was supported by: (1) a strong association between PHQ-9 and general health rating, (2) a single major factor with loadings exceeding 0.50, (3) item-total correlations exceeding 0.37 and (4) a pattern of item means similar to US validation studies. Four focus groups indicated culturally relevant content validity and minor modifications to the PHQ-9 instructions. Coefficient alpha was 0.78. Test-retest reliability was acceptable: (1) intra- class correlation 0.59 for PHQ-9 total score, (2) kappas 0.24, 0.25 and 0.38 for PHQ-9 MDD, ODD and any depressive disorder and (3) weighted kappa 0.53 for PHQ-9 depression severity categories. PHQ-2 ≥3 demon- strated high sensitivity (85%) and specificity (95%) for diagnosing any PHQ-9 depressive disorder (AUC, 0.97), and 91% and 77%, respectively, for diagnosing PHQ-9 MDD (AUC, 0.91). Psychometrics were also good within four gender/age (18–35, 36–61) subgroups. CONCLUSIONS: PHQ-9 and PHQ-2 appear valid/ reliable for assessing DSM-IV depressive disorderen_US
dc.language.isoenen_US
dc.publisherAmpathen_US
dc.subjectDepressionen_US
dc.subjectValidity/Reliabilityen_US
dc.titleValidity/Reliability of PHQ-9 and PHQ-2 Depression Scales Among Adults Living with HIV/AIDS in Western Kenyaen_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
File Description SizeFormat 
Yebei Violet Naanyu et.al.pdf240.35 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.